Cargando…

Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review

BACKGROUND: Polypharmacy, and the associated adverse drug events such as non-adherence to prescriptions, is a common problem for elderly people living with multiple comorbidities. Deprescribing, i.e. the gradual withdrawal from medications with supervision by a healthcare professional, is regarded a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulley, Joanna, Harrop, Deborah, Ali, Ali, Alton, Sarah, Fowler Davis, Sally
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339421/ https://www.ncbi.nlm.nih.gov/pubmed/30658576 http://dx.doi.org/10.1186/s12877-019-1031-4

Ejemplares similares

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Educating Homecare Nurses about Deprescribing of Medications to Manage Polypharmacy for Older Adults
por: Sun, Winnie, et al.
Publicado: (2021)

Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study
por: Ramsdale, Erika, et al.
Publicado: (2023)

Polypharmacy and deprescribing: challenging the old and embracing the new
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2022)

Deprescribing in Real Time: Hospitalized Septuagenarian With Polypharmacy
por: Famuyiro, Tolulope, et al.
Publicado: (2023)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

Nurse Practitioners’ Experiences of Polypharmacy in Community-Dwelling Older Adults
por: Pariseault, Christine, et al.
Publicado: (2020)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

Correction to: Polypharmacy and deprescribing: Challenging the old and embracing the new
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2022)

Continue or not to continue? Attitudes towards deprescribing among community-dwelling older adults in China
por: Tan, Jie, et al.
Publicado: (2022)

A Study on the Perceptions of Korean Older Adult Patients and Caregivers about Polypharmacy and Deprescribing
por: Lee, Han-Gyul, et al.
Publicado: (2022)

Polypharmacy and Medication-Related Problems in Hemodialysis Patients: A Call for Deprescribing
por: Alshamrani, Majed, et al.
Publicado: (2018)

Polypharmacy and the Change of Self-Rated Health in Community-Dwelling Older Adults
por: Barghouth, Muhammad Helmi, et al.
Publicado: (2023)

Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland
por: Zechmann, Stefan, et al.
Publicado: (2019)

“At 80 I Know Myself”: Embodied Learning and Older Adults’ Experiences of Polypharmacy and Perceptions of Deprescribing
por: Ross, Alison, et al.
Publicado: (2019)

Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial
por: Mortsiefer, Achim, et al.
Publicado: (2023)

Risk factors for self-reported medication adherence in community-dwelling older patients with multimorbidity and polypharmacy: a multicenter cross-sectional study
por: Liu, Jiaming, et al.
Publicado: (2023)

A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial
por: Vasilevskis, Eduard E., et al.
Publicado: (2019)

POLYPHARMACY, FRAILTY, AND DISABILITY-FREE SURVIVAL IN COMMUNITY-DWELLING HEALTHY OLDER INDIVIDUALS
por: Ekram, A R M Saifuddin, et al.
Publicado: (2022)

General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Deprescribing Leads to Improved Energy Intake among Hospitalized Older Sarcopenic Adults with Polypharmacy after Stroke
por: Matsumoto, Ayaka, et al.
Publicado: (2022)

Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy
por: Lefebvre, Melissa J., et al.
Publicado: (2020)

Multiple Medication Adherence and Related Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A Retrospective Cohort Study on Administrative Claims Data
por: Franchi, Carlotta, et al.
Publicado: (2022)

Theory-Based Interventions to Improve Medication Adherence in Older Adults Prescribed Polypharmacy: A Systematic Review
por: Patton, Deborah E., et al.
Publicado: (2016)

Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings
por: Elbeddini, Ali, et al.
Publicado: (2021)

Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
por: Lu, Lvliang, et al.
Publicado: (2023)

Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
por: Pollmann, André S., et al.
Publicado: (2015)

Deprescribing and Polypharmacy for Medicare Beneficiaries Under Guardianship in Long-Term Care Facilities
por: Swenson, Tami
Publicado: (2020)

The effects of in-hospital deprescribing on potential prescribing omission in hospitalized elderly patients with polypharmacy
por: Kaminaga, Miho, et al.
Publicado: (2021)

Polypharmacy Prevalence and Perceptions of Deprescribing in Elderly Patients Among Community Primary Care Providers in Mid-Michigan Practices
por: Zreik, Jad, et al.
Publicado: (2023)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

Policies for Deprescribing: An International Scan of Intended and Unintended Outcomes of Limiting Sedative-Hypnotic Use in Community-Dwelling Older Adults
por: Shaw, James, et al.
Publicado: (2019)

Frailty Status and Polypharmacy Predict All-Cause Mortality in Community Dwelling Older Adults in Europe
por: Midão, Luís, et al.
Publicado: (2021)

The Effect of a Comprehensive, Interdisciplinary Medication Review on Quality of Life and Medication Use in Community Dwelling Older People with Polypharmacy
por: Bosch-Lenders, Donna, et al.
Publicado: (2021)

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
por: Mantelli, Sophie, et al.
Publicado: (2018)

Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study
por: Clark, Collin M., et al.
Publicado: (2020)

Polypharmacy in the Older Adult: Medication Review in the Community
por: Pacetti, Staci, et al.
Publicado: (2020)

Number of medications and polypharmacy are associated with risk of fall in Saudi community-dwelling adults
por: Alenazi, Aqeel M.
Publicado: (2023)

Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study
por: Komagamine, Junpei, et al.
Publicado: (2018)

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey
por: Rozsnyai, Zsofia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_thkv2n3e94l8la3lm1rcsk6c2r